Innovative ETFs ChannelWill Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug?By Ian YoungJune 9, 2021
Beyond Basic Beta ChannelCan’t Get Enough Biotech Exposure in Your Portfolio?By Ben HernandezOctober 29, 2020
Alternatives ChannelEncouraging Election Year History for this Biotech ETFBy Tom LydonSeptember 11, 2020
Thematic Investing ChannelThere’s Still Plenty of Opportunity for Biotech Post-CoronavirusBy Tom LydonJune 16, 2020
Innovative ETFs ChannelBiotech ETFs Strengthen After Judge Blocks Trump’s Drug Pricing RuleBy Max ChenJuly 9, 2019
Equity ETFsBiotech ETFs Rally as Pence Promises ‘Orderly Transition’ Away from ObamacareBy Max ChenJanuary 4, 2017
